Home・Elenco Azioni・Anika Therapeutics Inc

Anika Therapeutics Inc

Aperta

SettoreSettore sanitario

21.48 2.33

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.57

Massimo

21.87

Metriche Chiave
By Trading Economics
Entrata	8.4M 3.3M
Vendite	3M 33M
EPS	0.3
Margine di Profitto	10.147
Dipendenti	235
EBITDA	8.3M 4.9M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	-0.8% downside

Dividendi
By Acuity
Utili prossimi	4 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	78M 277M
Apertura precedente	19.15
Chiusura precedente	21.48

Notizie sul Sentiment di mercato

By Acuity

50%

171 / 340 Classifica in Healthcare

Anika Therapeutics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 ago 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 ago 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 ago 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 ago 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 ago 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 ago 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 ago 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 ago 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 ago 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 lug 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

30 lug 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing a trend of five consecutive sessions of gains and maintaining strength above the 20-day moving average.

29 lug 2026, 22:01 UTC

Anika Therapeutics Inc shares are higher in after-market trading, amid notable volatility earlier. The stock remains above its 20-day moving average.

28 lug 2026, 19:36 UTC

Anika Therapeutics Inc shares are higher today, continuing a positive trend since Monday's close. The stock recently pulled back from earlier session highs.

27 lug 2026, 18:06 UTC

Anika Therapeutics Inc shares are higher Monday, reflecting a cumulative gain since Friday, amid broader market volatility influenced by declining oil prices.

24 lug 2026, 20:06 UTC

Anika Therapeutics Inc shares are higher today amid a positive market backdrop, despite some intraday volatility earlier in the session. No specific news was identified.

22 lug 2026, 20:13 UTC

Anika Therapeutics Inc. shares are lower in after-market trading, reflecting weak performance and broader market volatility amid rising crude oil prices.

21 lug 2026, 18:56 UTC

Anika Therapeutics Inc is trading higher, reflecting positive market sentiment, despite some intraday volatility earlier in the session. The stock remains elevated since Monday's close.

20 lug 2026, 19:06 UTC

Anika Therapeutics Inc shares are lower today, continuing a trend of declines over the past three sessions amid a broader market downturn in U.S. Treasuries.

Confronto tra pari

Modifica del prezzo

Anika Therapeutics Inc Previsione

Obiettivo di Prezzo

By TipRanks

-0.8% in calo

Previsioni per 12 mesi

Media 21 USD -0.8%

Alto 21 USD

Basso 21 USD

Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Anika Therapeutics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

2 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Anika Therapeutics Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

171 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.